Expression of Thymosin β4 Gene in Human Colorectal Cancer Tissues and its Clinical Significance

Rui ZHOU,Hong-yin YUAN,Bin XIONG,Ming MAO
DOI: https://doi.org/10.3971/j.issn.1000-8578.2005.09.006
2005-01-01
Abstract:Objective To study the expression of thymosin β4 in colorectal cancer and its clinical significance.Methods Forty-one cases of human colorectal cancer specimens was collected from the patients who received operation for colorectal cancer from 12/2003 to 11/2004. All of the specimens were determined for mRNA expression of thymosin β4 by using RT -PCR technique. Results Thymosin β4 mRNA was highexpressed in colorectal cancer specimens although they were also expressed in normal colorectal specimen. The results of semi-quantitative PT-PCR analysis showed the expression of thymosin β4 mRNA was 0.65± 0.21 and 0.42± 0.19 in cancer and normal tissues, respectively, P 0.01. The relative values of mRNA in lesions with metastatic lymph nodes ( 0.82± 0.23) was higher than those of non-metastatic lymph nodes ( 0.53± 0.19)(P 0.05); expression of thymosin β4 in Duke C or Duke D stage( 0.82± 0.22) was significantly higher than that in Duke A or Duke B stage ( 0.51± 0.18). There was a close relation between thymosin β4 mRNA expression and several clinicopathological factors including lymph node metastasis, and TNM stage.Conclusion Thymosin β4 gene expression in colorectal cancer may serve as a parameter for judging tumor biological characteristic and clinical significance.
What problem does this paper attempt to address?